Wockhardt Limited (WOCKPHARMA.NS)

INR 1310.1

(1.03%)

Operating Income Summary of Wockhardt Limited

  • Wockhardt Limited's latest annual operating income in 2023 was 140 Million INR , down -139.29% from previous year.
  • Wockhardt Limited's latest quarterly operating income in 2024 Q1 was 380 Million INR , up 200.0% from previous quarter.
  • Wockhardt Limited reported an annual operating income of -280 Million INR in 2022, down -151.85% from previous year.
  • Wockhardt Limited reported an annual operating income of 540 Million INR in 2021, up 120.27% from previous year.
  • Wockhardt Limited reported a quarterly operating income of -250 Million INR for 2023 Q1, down -19.05% from previous quarter.
  • Wockhardt Limited reported a quarterly operating income of 410 Million INR for 2023 Q2, up 264.0% from previous quarter.

Annual Operating Income Chart of Wockhardt Limited (2023 - 2005)

Historical Annual Operating Income of Wockhardt Limited (2023 - 2005)

Year Operating Income Operating Income Growth
2023 140 Million INR -139.29%
2022 -280 Million INR -151.85%
2021 540 Million INR 120.27%
2020 -2.66 Billion INR -185.92%
2019 -931.7 Million INR -199.68%
2018 -310.9 Million INR 84.83%
2017 -2.04 Billion INR -67.03%
2016 -1.22 Billion INR -132.66%
2015 3.75 Billion INR -44.89%
2014 6.81 Billion INR -18.84%
2013 8.39 Billion INR -57.31%
2012 19.67 Billion INR 47.92%
2011 13.3 Billion INR 64.61%
2010 8.08 Billion INR 14.69%
2009 7.04 Billion INR -4.27%
2008 7.35 Billion INR 28.76%
2007 5.71 Billion INR 4663.85%
2006 -125.24 Million INR -144.87%
2005 279.1 Million INR 0.0%

Peer Operating Income Comparison of Wockhardt Limited

Name Operating Income Operating Income Difference
Amrutanjan Health Care Limited 621.02 Million INR 77.457%
Biofil Chemicals and Pharmaceuticals Limited 20.65 Million INR -577.769%
Caplin Point Laboratories Limited 7.22 Billion INR 98.062%
FDC Limited 3.03 Billion INR 95.385%
Gufic Biosciences Limited 2.89 Billion INR 95.162%
Hikal Limited 1.49 Billion INR 90.63%
Ind-Swift Laboratories Limited 2 Billion INR 93.031%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 97.167%
Kilitch Drugs (India) Limited 208.05 Million INR 32.708%
Medico Remedies Limited 277.11 Million INR 49.48%
Nectar Lifesciences Limited 3.89 Billion INR 96.402%
Par Drugs and Chemicals Limited 551.58 Million INR 74.619%
RPG Life Sciences Limited 2.29 Billion INR 93.893%
Sequent Scientific Limited - INR -Infinity%
Shilpa Medicare Limited 3.76 Billion INR 96.278%
Sigachi Industries Limited 1.47 Billion INR 90.501%
Themis Medicare Limited 1.3 Billion INR 89.256%
Unichem Laboratories Limited - INR -Infinity%
Venus Remedies Limited 534.65 Million INR 73.815%
Wanbury Limited 1.7 Billion INR 91.799%
ZIM Laboratories Limited 1.09 Billion INR 87.251%
Lupin Limited 27.75 Billion INR 99.496%
Innova Captab Limited 2.53 Billion INR 94.474%
Ind-Swift Limited 1.22 Billion INR 88.58%
Bajaj HealthCare Limited - INR -Infinity%
Aurobindo Pharma Limited 104.5 Billion INR 99.866%
Solara Active Pharma Sciences Limited -3.85 Billion INR 103.634%
AstraZeneca Pharma India Limited 4.47 Billion INR 96.871%
Mangalam Drugs & Organics Limited 27.45 Million INR -409.87%
Morepen Laboratories Limited 4.17 Billion INR 96.646%
Laurus Labs Limited 3.94 Billion INR 96.454%
Aarti Drugs Limited 7.14 Billion INR 98.042%
Glenmark Life Sciences Limited 8.97 Billion INR 98.441%
Alembic Limited 767.77 Million INR 81.765%
Alembic Pharmaceuticals Limited 5.75 Billion INR 97.569%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 97.847%
Vaishali Pharma Limited 6.29 Million INR -2124.341%
Aarti Pharmalabs Limited 3.12 Billion INR 95.524%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 34.592%
Jubilant Pharmova Limited 5.18 Billion INR 97.302%
Eris Lifesciences Limited 5.18 Billion INR 97.298%
Windlas Biotech Limited 1.29 Billion INR 89.222%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 99.866%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 92.656%
Orchid Pharma Limited 2.36 Billion INR 94.071%
Albert David Limited 1.33 Billion INR 89.509%
Hester Biosciences Limited 364.77 Million INR 61.62%
Sakar Healthcare Limited 495.5 Million INR 71.746%
Suven Pharmaceuticals Limited 4.6 Billion INR 96.962%
Procter & Gamble Health Limited 2.78 Billion INR 94.975%
Divi's Laboratories Limited 18.31 Billion INR 99.235%
Mankind Pharma Limited 40.86 Billion INR 99.657%
Neuland Laboratories Limited 5.31 Billion INR 97.367%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 98.144%
Zydus Lifesciences Limited 45.39 Billion INR 99.692%
Bal Pharma Limited 214.56 Million INR 34.753%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 99.793%
Bliss GVS Pharma Limited 1.23 Billion INR 88.627%
Alkem Laboratories Limited 19.46 Billion INR 99.281%
Valiant Laboratories Limited - INR -Infinity%
Ajanta Pharma Limited 19.67 Billion INR 99.289%
Bafna Pharmaceuticals Limited 237.66 Million INR 41.093%
Aarey Drugs & Pharmaceuticals Limited 2.83 Million INR -4845.553%
Granules India Limited 6.52 Billion INR 97.855%
Medicamen Biotech Limited - INR -Infinity%
Ipca Laboratories Limited 29.59 Billion INR 99.527%
Brooks Laboratories Limited -72.25 Million INR 293.766%
Syncom Formulations (India) Limited 249.25 Million INR 43.832%
Piramal Enterprises Limited - INR -Infinity%
Torrent Pharmaceuticals Limited 25.33 Billion INR 99.447%
NATCO Pharma Limited 25.96 Billion INR 99.461%
Suven Life Sciences Limited -1.22 Billion INR 111.421%
Krebs Biochemicals & Industries Limited - INR -Infinity%
Strides Pharma Science Limited 5.22 Billion INR 97.321%
Indoco Remedies Limited 1.52 Billion INR 90.816%
Alpa Laboratories Limited 61.51 Million INR -127.587%
Lasa Supergenerics Limited -458 Million INR 130.567%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 103.402%